A5063462038- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- Childhood Cancer Survivors' Quality of Life
- COVID-19 and healthcare impacts
- Hemoglobinopathies and Related Disorders
- Web Data Mining and Analysis
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Nonmelanoma Skin Cancer Studies
- Cancer Risks and Factors
- Heart Failure Treatment and Management
- Cancer and Skin Lesions
- Artificial Intelligence in Healthcare
- Global Cancer Incidence and Screening
- Hedgehog Signaling Pathway Studies
- Chronic Myeloid Leukemia Treatments
- Web Applications and Data Management
- Venous Thromboembolism Diagnosis and Management
- Service-Oriented Architecture and Web Services
- COVID-19 diagnosis using AI
- Viral-associated cancers and disorders
- Complementary and Alternative Medicine Studies
- Cervical Cancer and HPV Research
Wroclaw Medical University
2019-2024
Patients with heart failure (HF) are at high risk of unfavorable courses COVID-19. The aim this study was to evaluate characteristics and outcomes COVID-19 patients HF.Data hospitalized in a tertiary hospital Poland between March 2020 May 2021 laboratory-confirmed were analyzed. population divided into HF group (patients history HF) non-HF group.Out 2184 (65 ± 13 years old, 50% male), 12% had HF. from the older, more often males, comorbidities, dyspnea, pulmonary peripheral congestion,...
Abstract One of the major pathomechanisms COVID-19 is interplay hyperinflammation and disruptions in coagulation processes, involving thrombocytes. Antiplatelet therapy (AP) by anti-inflammatory effect inhibition platelet aggregation may affect these pathways. The aim this study was to investigate if AP has an impact on in-hospital course medium-term outcomes hospitalized patients. population (2170 patients: mean ± SD age 60 19 years old, 50% male) divided into a group 274 patients receiving...
Imtroduction: The high-risk population of patients with cardiovascular (CV) disease or risk factors (RF) suffering from COVID-19 is heterogeneous. Several predictors for impaired prognosis have been identified. However, machine learning (ML) approaches, certain phenotypes may be confined to classify the affected and predict outcome. This study aimed phenotype using unsupervised ML technique within International Postgraduate Course Heart Failure Registry hospitalized Cardiovascular and/or RF...
The coronavirus disease 2019 (COVID-19) shows high incidence of thromboembolic events in humans. In the present study, we aimed to evaluate if anticoagulation prior COVID-19 infection may impact clinical profile, as well mortality rate among patients hospitalized with COVID-19. study was based on retrospective analysis medical records laboratory confirmed SARS-CoV-2 infection. After propensity score matching (PSM), a group 236 receiving any anticoagulant treatment (AT group) compared without...
Cancer is the second most common cause of death in Poland and number new cases expected to increase by 28% over next 10 years. Despite modifications expenditure growth Polish health care system, oncological treatment outcomes are lower comparing other European Union countries. Early preventative interventions effective reducing total cancers improving early detection. OnkoLogika an educational campaign launched 2016 Comprehensive Centre, aimed at cancer awareness. One hundred twenty students...
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Reszka K, Moskal Ł, Remiorz A, et al. The prevalence of complementary and alternative methods their impact on conventional cancer treatment among oncological patients in Poland – an institutional study. Medical Studies/Studia Medyczne. 2021;37(2):91-99. doi:10.5114/ms.2021.107452. APA Reszka, K., Moskal, Ł., Remiorz, A., Walas, Guzik, M., & Kierbiedź, N. (2021). Medyczne, 37(2), 91-99....
Abstract Hyperinflammation and coagulopathy with interaction platelets are the pathomechanisms responsible for unfavorable outcome of COVID-19. Therefore, role antiplatelet therapy (AP) in patients COVID-19 is uncertain. The aim this study was to investigate if AP has an impact on in-hospital course medium-term outcomes hospitalized patients. population (2170 patients: 60 (19) years old, 50% male) divided into a group 274 receiving any prior infection (AP group), after propensity score...
Background: The main objective of the treatment essential thrombocythemia (ET) is to reduce thrombohemorrhagic events. According last European LeukemiaNet (ELN) guidelines, hydroxycarbamide (HU) and interferon (IFN) are recommended as a first line therapy anagrelide (ANA) second‐line option in high‐risk patients with ET. literature, ANA not inferior HU, but some studies there was observed an association higher incidence arterial thrombosis, bleeding complications fibrotic progression. Thus,...